Recruiting

Observational Study

Sponsor:

GenBasix Incorporated

Code:

NCT00445562

Conditions

Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

biologic sample preservation procedure

informational intervention

Study Details

Brief summary:

RATIONALE: Collecting blood samples and health information from patients with invasive breast cancer and from their brothers and sisters over time may help the study of cancer in the future.

PURPOSE: This study is collecting blood samples and health information over time from patients with invasive breast cancer and from their brothers and sisters.

Conditions

Breast Cancer

Study ID

NCT00445562

Start date

Jan, 2001

Status verified date

Jul, 2009

Primary completion date

Dec, 2004

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

DISEASE CHARACTERISTICS:

  • Meets 1 of the following criteria:

  • Pathologically confirmed invasive breast cancer (patient)

  • No ductal carcinoma in situ
  • Affected OR unaffected sibling

  • Affected sibling must have had (or currently has) breast cancer only
  • Unaffected sibling must be female
  • No deceased siblings
  • Must be a full-blood related sibling
  • Patients receiving treatment on clinical trial ECOG-E1Y97 or ECOG-E3Y92 are not eligible

PATIENT CHARACTERISTICS:

  • Not specified

PRIOR CONCURRENT THERAPY:

  • Not specified

Study Design

Enrollment

1000 participants

Anticipated

Interventions and Outcome Measures

Interventions

biologic sample preservation procedure

informational intervention

Primary outcome measure

  • Collection of blood samples and medical and background information [ Time Frame: undefined ]

Central Contacts and Locations

Locations

GenBasix Incorporated

Recruiting

Duarte, California, United States, 91010

Contacts

Richard A. Shapiro, MD

800-248-4908

More Information

Sponsor

GenBasix Incorporated

Last update posted

Jul 10, 2013

Last verified

Jul, 2009

Keywords

  • male breast cancer
  • recurrent breast cancer
  • stage IA breast cancer
  • stage IB breast cancer
  • stage II breast cancer
  • stage IIIA breast cancer
  • stage IIIB breast cancer
  • stage IIIC breast cancer
  • stage IV breast cancer

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by GenBasix Incorporated on 2013-07-10.